ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CYT Cyteir Therapeutics Inc

3.02
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cyteir Therapeutics Inc CYT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 3.02 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.02 3.02
more quote information »

Recent News

Date Time Source Heading
3/07/202416:31EDGAR2Form 8-K - Current report
3/07/202416:30BWCyteir Announces Timeline for Voluntarily Delisting from..
3/05/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202419:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202419:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/27/202316:00EDGAR2Form 8-K - Current report
12/14/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:05EDGAR2Form 8-K - Current report
12/05/202316:05EDGAR2Form 8-K - Current report
11/22/202313:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:01EDGAR2Form 8-K - Current report
11/06/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/12/202316:14EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
10/12/202307:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/12/202307:51EDGAR2Form 8-K - Current report
10/12/202307:30BWOngoing Results From a Dose Expansion Cohort of CYT-0851 in..
10/05/202316:00EDGAR2Form 8-K - Current report
10/02/202316:44EDGAR2Form PREM14A - Preliminary proxy statements relating to..
8/07/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/30/202317:29EDGAR2Form 144 - Report of proposed sale of securities
6/30/202310:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
6/30/202310:22EDGAR2Form 8-K - Current report
6/30/202308:00BWCyteir Therapeutics Announces Discontinuation of CYT-0851..
6/03/202309:00BWPreliminary Ongoing Results with CYT-0851 in Combination..
5/10/202316:01BWCyteir Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock